The Impact of the Use of the MAURISSE Application in People Suffering From an Addiction.
ALMA
Study of Impact on Therapeutic Alliance in People With Addiction Using the MAURISSE Application.
1 other identifier
interventional
60
1 country
1
Brief Summary
Substance Use Disorders (SUD) are associated with cognitive schemas that lead to care attrition and mistrust towards care. Considering this, establishing a strong, trustful relationship between the patient and the healthcare team is important to promote patient engagement within SUD management. However, it requires an important availability of the healthcare team, allowing for frequent interactions at all times, including at night and during days off. We postulated that a mobile application called MAURISSE, which aims to help the caregivers maintaining a link with the patient in order to facilitate trust in the relationship, could foster patient engagement as well as the therapeutic alliance. This research aims to compare the effect of the application MAURISSE on the therapeutic alliance in a population of patients treated for a disorder related to substance use at the Toulouse University Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedStudy Start
First participant enrolled
September 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedSeptember 13, 2023
September 1, 2023
1.2 years
July 18, 2023
September 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The therapeutic alliance score assessed by the Working Alliance Inventory Short Revised scale (WAI-SR).
The Working Alliance Inventory-Short Revised is a scale that consists of two questionnaires. A 12-question questionnaire for patients and a 10-question questionnaire for caregivers. The questions are scored using a Likert scale ranging from 1 to 5
2 months
Study Arms (2)
Application group
EXPERIMENTALPatients randomized to the digital application arm will benefit from treatment as usual and will have access to the MAURISSE application, allowing them to communicate with the healthcare team using a messaging system, to report and follow substance use, to access a To-do list, to access personal multimedia contents helping with the treatment, to report a feeling of boredom (these moments presenting a risk of relapse) and finally to access a list of propositions in order to fight this feeling
Standard-of-care group
ACTIVE COMPARATORThese patients will benefit from the usual care within the center (appointments with doctors; regular follow-up meetings with nurses, psychologists, social workers, therapeutic groups depending on the evaluation).
Interventions
* Exchanges with the care team via the messaging system, * Postponement of consumption, * Monitoring of consumption, * Access to information on the To Do List, * Access to personal content to help with management (Socio-professional situation, type of life, personal history..). * Postponement of a feeling of boredom, * Access to proposals to fight against this feeling.
The usual care within the center will consist of appointments with doctors; regular follow-up meetings with nurses, psychologists, social workers, therapeutic groups depending on the evaluation.
Eligibility Criteria
You may qualify if:
- Patient over 18 years old,
- Starting specialized treatment for addiction (addiction to substance and behavioral addiction too as money games addiction).
- Suffering from any type of addiction, with an active addiction requiring weekly monitoring of substance use.
- possessing a smartphone or having access to a smartphone and having access to an internet connection.
- Able to read and understand French.
- Affiliated or beneficiary of a social security scheme.
You may not qualify if:
- Patient with cognitive or psychiatric disorders that may affect their ability to consent.
- Participation in another protocol involving a modification of the treatment for addiction.
- Known or suspected pregnancy.
- Person under legal protection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Toulouse
Toulouse, 31059, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juliette SALLES
University Hospital, Toulouse
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2023
First Posted
July 27, 2023
Study Start
September 7, 2023
Primary Completion
November 1, 2024
Study Completion
March 1, 2025
Last Updated
September 13, 2023
Record last verified: 2023-09